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Abstract
Background: Patients received electrochemotherapy often associated with unpleasant sensations mainly
result from low-frequency electric pulse induced muscle contractions. Increasing the repetition frequency
of electric pulse can reduce unpleasant sensations. However, due to the specificity of SPEF, frequency
related antitumor efficiency need to be further clarified. The aim of this study was to compare in vitro
cytotoxic and in vivo antitumor effect on ovarian cancer cell line SKOV3 by SPEF with different repetition
frequencies. Explore potential benefits of using high frequency SPEF in order to be exploitable in
electrochemotherapy.
Methods:  For in vitro experiment, SKOV3 cell suspensions were exposed to SPEF with gradient
increased frequencies (1, 60, 1 000, 5 000 Hz) and electric field intensity (50, 100, 150, 200, 250, 300, 350,
400 V/cm) respectively. For in vivo test, SKOV3 subcutaneous implanted tumor in BALB/c nude mice (nu/
nu) were exposure to SPEF with gradient increased frequencies (1, 60, 1 000, 5 000 Hz) and fixed electric
field intensity (250 V/cm) (7 mice for each frequency and 7 for control). Antitumor efficiency was
performed by in vitro cytotoxic assay and in vivo tumor growth inhibition rate, supplemented by
histological and TEM observations. Data were analyzed using one-way ANOVA followed by the
comparisons of multiple groups.
Results:  SPEF with a given frequency and appropriate electric field intensity could achieve similar
cytotoxicity until reached a plateau of maximum cytotoxicity (approx. 100%). SPEF with different
frequencies had significant antitumor efficiency in comparison to the control group (P < 0.05). However,
there was no difference in tumor responses among test groups (P > 0.05). Histological and TEM
observations demonstrated obvious cell damages in response to SPEF exposure. Furthermore, SPEF with
5 kHz could induce apoptosis under TEM observations both in vitro and in vivo.
Conclusion: SPEF with high frequency could also achieve similar antitumor efficiency which can be used
to reduce unpleasant sensations in tumor electrical treatment. Our research proposed potential
applications of using high frequency SPEF in clinical cancer treatment.
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Background
Electric field is a new biomedical engineering technique
which can be used as electrochemotherapy, tumor abla-
tion, or intracellular electromanipulation respectively
[1,2]. The biological basis of electrohemotherapy is the
combination of reversible membrane electroporation
caused by weak intensity microsecond electric pulse and
subsequent enhanced intracellular drug-uptake such as
bleomycin and cisplatin for their cytotoxicity [3]. Alterna-
tively, distinct from electrochemotherapy, irreversible
membrane electroporation induced by intensive energy
microsecond electric pulse can be used alone to imple-
ment tumor ablation directly without any cytotoxic drugs
[4-6]. Furthermore, different from microsecond electric
pulse, nanosecond electric pulse decreases its effect on
plasma membrane and imposes electric force on multiple
subcellular structures known as intracellular electroma-
nipulation, which can be used in cancer treatment, gene
therapy and wound healing [7]. Therefore, electric field
possesses parameters related different biophysical effects.
However, to the best of our knowledge, few researchers
have involved any information about the biophysical
effects regarding the combined application of microsec-
ond and nanosecond duration electric pulse in cancer
treatment.
Our group has dedicated to investigate antitumor effects
of SPEF for many years. The distinct characteristic of this
exponential decayed SPEF was that the rising period was
shortened to the nanosecond level which contains abun-
dant high frequency electromagnetic components (we call
it steep pulsed electric fields), and the descending period
remained in the microsecond level which contains lots of
low frequency electromagnetic components [8]. There-
fore, this specially designed SPEF composed of a dual
component type of pulse, which different from microsec-
ond duration, low repetition frequency electric fields typ-
ically used in electrochemotherapy. For the first time, we
confirmed that the combined effect of micro- and nano-
second electric pulse contained in SPEF could destroy can-
cer cells effectively through reversible or irreversible mem-
brane electroporation [8-12] or trigger various
biophysical responses within caner cells [13]. Further-
more, the killing effect of SPEF depended on pulse param-
eters, excessive electric field intensity could cause extra
damage to surrounding normal tissue [14].
Repetition frequency of electric pulses was considered to
have a close relationship to the contraction of muscle,
which can lead to painful burning sensation in electroche-
motherapy and often complained by many patients [15].
Increasing the repetition frequency of electric pulse deliv-
ery can reduce unpleasant sensations that occur in electro-
chemotherapy [15]. On the other hand, with respect to
pulse frequency on antitumor efficiency, authors report
that microsecond duration electric pulse with high repeti-
tion frequency actually doesn't decrease its antitumor effi-
ciency in electrochemotherapy [16,17]. However, besides
the pulse frequency that induces unpleasant sensations
during electrochemotherapy, pain sensation also depends
on pulse parameters such as pulse amplitude, number,
duration, and shape of the pulses [18]. Therefore, due to
the specificity of SPEF, further studies were still necessary
to elucidate the effects of frequency related antitumor effi-
ciency by the dual component type of pulse in SPEF.
In this study, we primarily aimed to compare in vitro cyto-
toxic and in vivo antitumor effect on ovarian cancer cell
line SKOV3 by SPEF with different repetition frequencies.
Our objective was to explore the effect of such electric
pulses in order to be exploitable in electrochemotherapy.
We reported in the article that SPEF with high repetition
frequency (5 kHz) can also achieve similar levels of in
vitro and in vivo antitumor efficiency. Furthermore, SPEF
with 5 kHz could induce apoptosis under ultrastructural
observations both in vitro and in vivo. It is hoped that this
study would be helpful to evaluate the potential use of
high frequency SPEF to reduce unpleasant sensations
without decreasing therapeutic effect in clinical tumor
electrical treatment. The conclusions can finally lead to
new therapeutic approach in electrochemotherapy.
Materials and methods
Materials
Cell Culture
Human ovarian cancer cell line SKOV3 (Shanghai Bio-
chemical Institution, Shanghai, China) was initially cul-
tured in RPMI-1640 medium supplemented with 2 mM
glutamine, 10% fetal bovine serum (FBS), 2% penicillin
and streptomycin, and were maintained at 37°C and 5%
CO2. Fetal bovine serum, RPMI-1640, MTT, DMSO, were
provided by Sigma Company (Sigma-Aldrich, Inc St.
Louis, MO, USA). Na-phenobarbital was provided by
Fuyang Pharmaceutical Factory (Anhui, China).
Tumor Formation in BALB/c nude mice
BALB/c nude mice (nu/nu) (n = 35, 8-week-old, weighing:
25–28 g) were used for this study. Mice were kept at con-
stant room temperature (25°C) with a natural day/night
light cycle under SPF conditions with food and water pro-
vided ad libitum. Before experiments, all rats were sub-
jected to an adaptation period of at least 10 days, without
fungal or other infectious disease at the beginning of
experiment. Animals were maintained in accordance with
the principles outlined in the National Institute of Health
Guide for the care and use of laboratory animals. MiceJournal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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were provided by the Medical Experimental Animal
Administrative Committee of Wenzhou Medical College,
China (animal certification number: SCXK-20020001).
Solid subcutaneous tumor, located right rear limb in
mice, was initiated by an injection of 2 × 106 SKOV3 cells
in 0.2 ml 0.9% NaCl solution. The viability of the cells
was over 95% as determined by a trypan blue dye exclu-
sion test. Then tumor tissue was cut and implanted subcu-
taneously to establish tumor bearing mice. Six to 10 days
after implantation when subcutaneous tumor nodules
reached approximately (120.5 ± 18.2) mm3, tumor model
was successfully established and subjected to electric
fields stimulation protocols.
SPEF Exposure System
SPEF generator was designed by Sun et al., in the key lab-
oratory of high voltage engineering and electrical new
technology of Chongqing University [9]. The pulse curve
was in form of unipolar exponential decay with the
utmost voltage peak value 1000 V, pulse rise time ranging
from 90–180 ns, pulse total duration 1–20 μs, and the fre-
quency 1 Hz–5 kHz. Parameters in combination pro-
duced desired energy-controllable SPEF.
Electric Fields Stimulation Protocols
We used Tektronix TDS3032B Oscilloscope to monitor
SPEF output and typical waveform captured referred to
Figure 1. The parameters used for in vitro experiment
referred to Table 1: eight unipolar exponential decay
pulses with each 20 μs duration (rise time was 160 ns),
with amplitudes from 50 to 400 V/cm, and pulse repeti-
tion frequencies of 1, 60, 1 000, 5 000 Hz were delivered
(cell exposure time was 30 minutes).
The parameters used in SKOV3 implanted tumor referred
to Table 2: eight unipolar exponential decay pulses with
each 20 μs duration (rise time was 160 ns), with electric
field intensity 250 V/cm, and pulse repetition frequencies
of 1, 60, 1 000, 5 000 Hz were delivered (cell exposure
time was 30 minutes).
In this paper, we adjusted, the frequency of the pulses by
changing the interval between two consecutive pulses in a
train, and then keeping both the duration and number of
pulses constant. Cell culture and SPEF-exposure were per-
formed at room temperature (25°C) and data analysis
was conducted in a blinded fashion.
Determination of Frequency Related Antitumor Efficiency
In Vitro Cell Exposure and Cytotoxicity of SPEF
SKOV3 cells were digested with 0.25% trypsin and resus-
pended into steriled 24-well culture plate with average cell
density being 1 × 105 cells/well. This self – made 24 – well
culture plate was equipped with an array of platinum nee-
dle electrodes (0.3 mm in diameter, 10 mm long, 10-mm
apart) mounted on a plastic holder to keep the distance
constant and reproducible, with each well correspond to
a pair of parallel electrodes connections to SPEF genera-
tor. This device can perform repeated experiments to
ensure consistency and repeatability of the testing results.
Control cells in 24-well plates received no electric stimu-
lation.
After each exposure to a combined frequencies and elec-
tric field intensity (Table 1), for each test group, cytotoxic-
ity of SPEF on SKOV3 was evaluated by MTT assay. Cells
were then incubated with MTT (5 mg/ml) for 4 hours and
DMSO (0.1%, V/V) for 10 minutes to perform MTT assay
[19]. Optical density (OD) was determined at 490 nm by
using a microplate reader (BIO-RAD, model 550, USA).
Non-treated cells in self – made 24 – well culture plate
served as control, and also got MTT assay in the same way.
For each test group, a corresponding cytotoxicity was cal-
culated and the data shown were representative of the
mean of at least three independent experiments on differ-
ent days.
Cytotoxicity was determined according to the equation: %
cytotoxicity = (control value - experimental group)/(con-
trol value) × 100%. Moreover, drew the curve of cytotox-
icity of SPEF for SKOV3 under different frequencies and
electric field intensity.
In Vivo Tumor Exposure and Tumor Volume Inhibition Efficiency
Twenty-eight established tumor bearing mice were ran-
domly divided into four experimental groups (7-mice in
each frequency group) and subjected to a relevant SPEF
exposure protocol using platinum needle electrodes (0.3
mm in diameter, 10 mm long, 10-mm apart) on day 0
Table 1: The parameters of SPEF used in SKOV3 cell suspensions.
Test
group
Frequency
(Hz)
Intensity
(V/cm)
Rise time
(ns)
Duration
(μs)
Stimulation time
(minutes)
Group 1 1 50, 100, 150, 200, 250, 300, 350, 400 160 20 30
Group 2 60 50, 100, 150, 200, 250, 300, 350, 400 160 20 30
Group 3 1 000 50, 100, 150, 200, 250, 300, 350, 400 160 20 30
Group 4 5 000 50, 100, 150, 200, 250, 300, 350, 400 160 20 30
In the first procedure, each intensity constituted a separate experiment contained in a certain test group, and cell exposure time was 30 minutes for 
each intensity corresponding to a given frequency.Journal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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(Table 2). Another 7-mice in non-exposure group served
as control. All mice received anaesthetized by Na-pheno-
barbital (i.p.:30 mg/kg body weight) during SPEF expo-
sure. Then mice were maintained under SPF conditions.
Tumor size was measured in all mice accurately with a dig-
ital calliper before and every day after SPEF exposure.
Tumor volumes were calculated from the equation: V =
π·A·B·C/6 (mm3) (A length, B width, C height) [17]. On
the 26th day after SPEF exposure, tumor volume inhibition
rate was calculated by using the equation: Inhibition rate
= (1- tumor volume of test group/tumor volume of con-
trol group) × 100% [20]. Moreover, drew the tumor
growth curve of tumor volume according to observation
time for each frequency group.
Light and TEM Observation
After in vitro exposure to SPEF, SKOV3 cell samples in
each experimental group were subjected to multi-step
processes and finally rendered to TEM observation (H-
600, HITACHI, Hitachi Ltd, Japan). Non-treated control
cells also get TEM assay in the same way.
After in vivo exposure to SPEF, one mouse from each
experimental group and control group were fed for 3 days
before received same anesthesia and tumor tissue sam-
pling. Tissue blocks (1-cm3) were then processed for HE
staining and routine pathologic observation by light
microscopy. The rest of tumor tissue blocks (1-mm3) were
subjected to the identical procedures for TEM analysis.
Other 6-mice in each group were continuously fed for
above-mentioned tumor volume inhibition analysis.
Statistical Analysis
Statistical analyses were performed using SPSS for win-
dows 11.0. Data were presented as mean ± S.D, and were
subjected to analysis using one-way ANOVA, followed by
multiple comparisons among test groups or by Dunnett's
test for comparisons between test and control groups.
Results
During the whole experiment, SPEF exposure was well tol-
erated in all mice. No obvious abnormality in behavior or
gross anatomy was observed and no animal death
occurred in any groups due to anesthetics or SPEF expo-
sure.
In Vitro Cytotoxicity of SPEF
MTT assay showed that cytotoxicity depended on pulse
frequencies and electric field intensity (Figure 2). From
the curve, at a given frequency, cytotoxicity of SPEF
increased in parallel with electric field intensity. At a given
intensity, SPEF with frequency at 1 Hz showed the strong-
est cytotoxicity among four groups; increased frequency
led to decreased cytotoxicity, presented as the curve of
cytotoxicity shifted to the right. We could find that higher
repetition frequencies seem to require intensive electric
field intensity to obtain the maximum cytotoxicity. SPEF
with a given frequency and intensity can achieve similar
cytotoxicity until reached a plateau of maximum cytotox-
icity (approx. 100%). Typically, when frequency reached
to 5 kHz, SPEF with intensive energy could also achieve
similar cytotoxicity in comparison to low frequency SPEF
with weak intensity.
In Vivo Antitumor Efficiency of SPEF
Tumor volume and growth curve at different observation
time were recorded and compared among test and control
groups (Figure 3). Each point on the figure represented
the mean value of six mice. At he time of the 26th day,
tumor volume of test groups and volume inhibition rate
Typical waveform of SPEF captured by Tektronix TDS3032B  Oscilloscope Figure 1
Typical waveform of SPEF captured by Tektronix 
TDS3032B Oscilloscope.
Table 2: The parameters of SPEF used in SKOV3 implanted tumor.
Test
Group
Frequency
(Hz)
Intensity
(V/cm)
Rise time
(ns)
Duration
(μs)
Exposure time
(minutes)
test 1 1 250 160 20 30
test 2 60 250 160 20 30
test 3 1 000 250 160 20 30
test 4 5 000 250 160 20 30
In the second procedure, each frequency constituted a separate experiment, and tumor exposure time was 30 minutes for each frequency.Journal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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were 557.5 ± 59 mm3 and 26.2% (corresponding to SPEF
with frequency of 1 Hz), 581.2 ± 67 mm3 and 23% (60
Hz), 534.5 ± 48 mm3 and 29.2% (1 kHz), 513.9 ± 42 mm3
and 31.9% (5 kHz), while tumor volume in control group
was 701.3 ± 74.2 mm3. Tumor growth in test groups were
significantly lower than that in control group (Dunnett's
test, all P < 0.05), indicated that SKOV3 implanted tumor
was inhibited evidently by SPEF with different frequen-
cies. On the contrary, multiple comparisons showed no
significant difference among test groups (one-way
ANOVA, all P > 0.05), indicated that SPEF with different
frequencies had similar antitumor efficiency.
Routine Pathologic Observation
Cancer tissue in the control group grew actively and pre-
sented with sheet distribution, high cellularity of cancer
cells, multinucleate cancer cells and increased signs of
pathologic mitosis (Figure 4A). Three days after exposure
to SPEF (5 kHz), extensive necrosis could be seen in can-
cer tissue (Figure 4B).
Ultrastructural Observation
The following ultrastructural changes manifested the irre-
versible damage of tumor cells in response to SPEF expo-
sure.
TEM observation showed abundant mitochondria and
nucleoli with increased karyoplasm ratio in non-exposure
SKOV3 (Figure 5A). However, in response to SPEF expo-
sure (1 kHz), SKOV3 plasma membrane and karyotheca
was disintegrated, subcellular organelles such as mito-
chondria, endoplasmic reticulum and nucleus were cavi-
tated and swollen (Figure 5B). Similarly, the integrality of
cell membrane also was destroyed along with pyknosis,
karyorrhexis and karyolysis in SKOV3 implanted tumor (1
kHz) (Figure 6A). In addition to so much irreversible
damage, typical characteristic of apoptosis was further
induced by SPEF exposure (5 kHz) (Figure 5C and 6B).
Discussion
Pulsed Electric Fields in Tumor Electrical Treatment
Recent advance in biomedical engineering has enabled
great progress in pulsed electric fields. Microsecond elec-
tric pulse with weak intensity can create reversible mem-
brane electroporation to enhance drug-uptake such as
The cytotoxicity of SPEF with different frequencies and elec- tric field intensity on SKOV3 Figure 2
The cytotoxicity of SPEF with different frequencies 
and electric field intensity on SKOV3. Each point on the 
figure represents the mean value of three independent 
experiments. For each line, SPEF with a given frequency and 
appropriate electric field intensity can achieve similar cyto-
toxicity until reach a plateau of maximum cytotoxicity 
(approx. 100%).
Tumor volume and growth curve at different observation  time among groups Figure 3
Tumor volume and growth curve at different obser-
vation time among groups. Each point on the figure rep-
resents the mean ± S.D. of six mice. SPEF with different 
frequencies showed significant antitumor efficiency in com-
parison to the control group (Dunnett's test, all P < 0.05). 
However, there was no difference in tumor responses 
among test groups (one-way ANOVA, all P > 0.05).
Routine pathologic observation of SKOV3 subcutaneous  implanted tumor in BALB/c nude mice Figure 4
Routine pathologic observation of SKOV3 subcutane-
ous implanted tumor in BALB/c nude mice. 4A. Can-
cer tissue in the control group grew actively and presented 
with sheet distribution, high cellularity of cancer cells, multi-
nucleate cancer cells and increased signs of pathologic mito-
sis. (HE × 400). 4B. Three days after exposure to SPEF (5 
kHz), extensive necrosis could be seen in cancer tissue. (HE 
× 200).Journal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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chemotherapeutic drugs, antibody and exogenous macro-
molecule substance which are impermeable under nor-
mal conditions. Reversible electroporation can be used in
electrochemotherapy to sensitize cancer cells to anticancer
drugs or in transcutaneous drug delivery [3]. An European
project (European Standard Operating Procedures of Elec-
trochemotherapy, ESOPE) had proven electrochemother-
apy to be an easy, highly effective, safe and cost-effective
approach for the treatment of cutaneous and subcutane-
ous tumors of different malignancies [21,22]. Further-
more, Microsecond electric pulses with intensive energy
often induce irreversible membrane electroporation
which can be used to implement tumor ablation directly
without any drugs [5]. On the other hand, when shorten
the duration of the pulse from microsecond to nanosec-
ond, nanosecond electric pulse can penetrate the intact
plasma membrane to impose electric force on multiple
subcellular structures and induce multiple biophysical
effects known as intracellular electromanipulation, which
can be used in cancer treatment, gene therapy and wound
healing [7].
The application of microsecond or nanosecond electric
pulse in caner treatment has been the focus and was
widely accepted by researchers. However, to our knowl-
edge, few researchers have investigated the biophysical
effects regarding the combined application of microsec-
ond and nanosecond duration electric pulse in cancer
treatment. Recently, according to an "online release"
appeared on the official website of the Frank Reidy
Research Center for Bioelectrics in Old Dominion Univer-
sity, a dual pulsing system combining long pulses, which
open pores in the outer cell membrane, and short pulses,
that affect intracellular structures and molecular trans-
port, to enhance gene delivery to the nucleus, was under
development [23].
For the first time, we reported the use of both types of elec-
tric pulse in this study. We were convinced that the appli-
cation of this new technology would be of great value in
clinical medicine. SPEF was a kind of electric energy trans-
mission method which was unique from existing micro-
or nano-second electric pulse. It was designed to combine
micro- and nano-second electric pulse into one integral
exponential decayed pulses simultaneously. SPEF had a
fast rise-time at nanosecond level, containing a large spec-
trum of high electromagnetic frequencies, and a long
queue at microsecond level with low electromagnetic fre-
quencies. According to Hofmann's electric circuit cell
model [24], microsecond pulse with low frequency elec-
tromagnetic fields mainly cause energy deposition in cell
membrane and create reversible or irreversible electropo-
ration, nanosecond pulse with high frequency electro-
magnetic fields can scramble subcellular organelles [1,7].
Therefore, the two components of SPEF allow combined
killing effects on cell membrane and on the subcelluar
organelles simultaneously. We had confirmed that SPEF
with different parameters could exert different biophysical
effects [8-13] and destroy target area in an intensity-
dependent manner [14].
Patients received electrochemotherapy often associated
with unpleasant sensations, mainly result from low-fre-
quency (1 Hz) electric pulse induced muscle contractions
[25]. Zupanic et al., demonstrated that pulse repetition
frequency had a close relation to muscle contraction,
increasing the pulse repetition frequencies which higher
Microphotos of SKOV3 cells under TEM observation Figure 5
Microphotos of SKOV3 cells under TEM observation. 
5A: Abundant mitochondria and nucleoli with increased kary-
oplasm ratio in non-exposure cells. (TEM × 3500). 5B: In 
response to SPEF exposure (1 kHz), SKOV3 plasma mem-
brane and karyotheca was disintegrated, subcellular 
organelles such as mitochondria, endoplasmic reticulum and 
nucleus were cavitated and swollen. (TEM × 3500). 5C: Typi-
cal characteristic of apoptosis was further induced by SPEF 
exposure (5 kHz). (TEM × 10000).
Microphotos of SKOV3 subcutaneous implanted tumor  under TEM observation. (TEM × 10000) Figure 6
Microphotos of SKOV3 subcutaneous implanted 
tumor under TEM observation. (TEM × 10000). 6A: In 
response to SPEF exposure (1 kHz), the integrality of cell 
membrane was destroyed along with pyknosis, karyorrhexis 
and karyolysis. 6B: Typical characteristic of apoptosis was 
further induced by SPEF exposure (5 kHz).Journal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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than tetanic could reduce unpleasant sensations that
occur in electrochemotherapy [15]. With respect to elec-
troporation efficiency, Pucihar et al., discovered the
absence of a direct influence of high frequency microsec-
ond electric pulse on the uptake into electropermeabilized
cells in vitro [16]. Furthermore, similar results by Mik-
lavcic et al., also described that high frequency microsec-
ond electric pulse actually didn't decreased its antitumor
efficiency in electrochemotherapy [17]. On the other
hand, pain sensation during electrochemotherapy also
involves pulse parameters such as pulse amplitude,
number, duration, and shape of the pulses [18]. Gener-
ally, for efficient electrochemotherapy, electric pulses of
appropriate parameter must be delivered to the target tis-
sues. However, due to the specificity of SPEF, little data
were known regarding the effect of different pulse fre-
quencies on in vitro and in vivo antitumor efficiency by
the dual component type of pulse in SPEF.
In Vitro and In Vivo Antitumor Efficiency of SPEF
In this paper, we studied in vitro and in vivo antitumor
efficiency by SPEF with different frequencies and electric
field intensity. In vitro test showed that cytotoxicity of
SPEF increased in parallel with electric field intensity.
SPEF with a given frequency and electric field intensity
could achieve similar cytotoxicity until reached a plateau
of maximum cytotoxicity (~100%). Increased pulse repe-
tition frequencies didn't significantly reduce the maxi-
mum value of the cytotoxicity even at the highest
frequency (5 kHz). However, higher electric field intensity
seemed to be required to obtain the maximum cytotoxic-
ity with the increased repetition frequency of electric
pulses. SPEF with 1 Hz or 5 kHz could achieve similar
cytotoxicity when accompanied by appropriate electric
intensity. Previous research performed by Pucihar et al.,
also revealed similar result, DC3F cell suspension was
exposure to microsecond duration electric pulse, they
proved that even if the frequencies reached to 8.3 kHz,
electroporation efficiency and the uptake into in vitro
electropermeabilized DC3F cells remained unchanged
[17].
In the following test, SPEF with increased frequencies (1,
60, 1 000, 5 000 Hz) and fixed electric field intensity (250
V/cm) were introduced into SKOV3 subcutaneous
implanted tumor in BALB/c nude mice. In vivo antitumor
assay showed that SPEF with different frequencies had sig-
nificant antitumor effect in comparison to the control
group. However, we did not observe any difference in
antitumor efficiency among different frequencies even if
the frequencies reach 5 kHz. Daskalov et al., also revealed
similar result, electrochemotherapy with high frequency
pulses was performed on basal cell and spin cell carci-
noma and on melanoma metastases in patients. No differ-
ence in tumor responses was observed between 1-Hz and
1 kHz bipolar rectangular pulses [26]. Heller et al., also
reported that the benefits from the use of high frequency
electric pulses including overcoming the resistance of tar-
get tissue and reaching effective depth of interaction [27].
Furthermore, Chang and coworkers had also reported
high efficiency gene transfection by membrane electropo-
ration using a radio-frequency electric field (40-kHz fre-
quency) [28].
Further study confirmed that SPEF with 5 kHz could
induce apoptosis observed by TEM both in vitro and in
vivo. We proposed that induced apoptotic effect was prob-
ably a consequence of scramble effects on the target sub-
cellular organelles by the nanosecond pulse component
in high frequency SPEF. Our previous study also demon-
strated that SPEF with appropriate parameters could trig-
ger cell apoptosis through intracellular calcium
electromanipulation [13]. Another study by Weaver et al.,
also revealed that high frequency electromagnetic fields
could cause mitochondrial electropermeabilization,
inhibit energy generation and cell proliferation, further
induced apoptosis [1].
Potential Use of High Frequency SPEF in 
Electrochemotherapy
Motor nerves of skeletal muscle in most mammals were
mainly composed of myelinated nerve fibres. The data on
the maximum frequency of generated action potentials
were calculated to be about 400~2500 Hz (inverse value
of the duration of the action potential and the refractory
period) regarding to the absolute refractory period which
depending on the axonal diameter, myelinated thickness
and the number of myelinated nerve fiber [29]. As we
know, electrical stimulation during absolute refractory
period lead to null muscle contractility. Practically, elec-
tric pulse with a train of 8-pulses at standard repetition
frequency of 1 Hz has been typically used in traditional
electrochemotherapy for many years [17]. However, it
deserves to be specially noted that, the limitation of such
stimulus is that each individual pulse delivered consecu-
tively can become an active stimulus, activate motor
nerves in neuromuscular junctions around the electrodes
and then generate an isolated muscle contraction. As
reported in the literature, approximately 40 Hz electric
stimulation will fuse successive muscle contractions into
smooth motion-tetanic contraction [29]. With pulse repe-
tition frequencies below the frequency of tetanic contrac-
tion (approx. 40 Hz for humans), increasing the
frequency of electric pulses would shorten the delay
between two consecutive muscle contractions and subse-
quently increased muscle contraction. Ultimately provoke
sustained contraction of muscle (tetany) and painful
burning sensation in electrochemotherapy [15]. In addi-
tion, low frequency electric pulse can directly irritate nerve
endings of pain receptors to cause intensive pain. There-Journal of Experimental & Clinical Cancer Research 2009, 28:53 http://www.jeccr.com/content/28/1/53
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fore, researchers now advocate discarding the use of low
frequency electric pulse for electrochemotherapy [17].
Interestingly, however, the benefits of this unique charac-
teristic of low frequency electric pulse had been widely
used in neuromuscular electrical stimulation for patients
suffered from peripheral facial paralysis [30].
The aim of our study was to employ high frequency elec-
tric pulse for tumor electrical treatment. We speculated
that when the delay between two consecutive electric
pulses was shorter than the duration of the action poten-
tial and the refractory period, also can be interpreted as,
the pulses repetition frequencies were higher than the fre-
quency of tetanic contraction (approx. 40 Hz). In this
case, single or multiple electrical pulses in one repetition
frequency will skip out of the absolute refractory period
which is essential to generate action potentials and initi-
ate muscle contractility. Subsequently, achieve the pur-
pose of reducing sustained contraction of muscle (tetany)
and relieve painful sensation. Miklavcic et al., also
reported that at pulse frequencies higher than 2000 Hz,
the muscle torque was similar to that after application of
a 1 Hz pulse train (a typical electrochemotherapy proto-
col) [17]. It is thus evident that, increasing the repetition
frequency even far exceeds the frequency of tetanic con-
traction, electric pulse doesn't sharpen the pain in tumor
electrical treatment.
It should be highlighted that Marty and colleagues newly
developed a machine called Cliniporator™ (Igea s.r.l.
Carpy, Italy) that had been certified to use on patients in
the European market along with the ESOPE project for the
treatment of cutaneous and subcutaneous tumors of dif-
ferent malignancies. It can generate the 5 kHz microsec-
ond electric pulses which is now being used prevalently in
the most of electrochemotherapy treatments [21,22].
More recent studies by Marty et al., [21] and Mir et al.,
[22] and Sersa et al., [31] showed in their clinical studies,
that electrochemotherapy with Cliniporator™ at a repeti-
tion frequency of 5 kHz could reduce the number of con-
tractions to one and there was no difference in the level of
pain when compared to 1 Hz. Furthermore, they found
that the 5 kHz repetition frequency of the applied electric
pulses resulted in statistically significantly better antitu-
mor effect than the 1 Hz repetition frequency. Their stud-
ies also suggested that the use of 5 kHz frequency had the
advantages in shortening the treatment time, especially in
the treatment of multiple tumor nodules.
Conclusion
We demonstrated that, SPEF with high repetition fre-
quency could also achieve similar levels of in vitro and in
vivo antitumor efficiency which could be used to reduce
unpleasant sensations that occurred in tumor electrical
treatment. In addition, rich components of nanosecond
pulse contained in SPEF with high frequency electromag-
netic fields (5 kHz) could induce cell apoptosis and pro-
vided complementary antitumor effect for the marginal
regions with weak electric fields. Our research proposed
potential applications and feasibility of using high fre-
quency SPEF in clinical cancer treatment.
Nevertheless, it should be noted that this study examined
only in vitro and in vivo antitumor effect of SPEF with var-
ious frequencies. However, effects of pulse repetition fre-
quencies on biomechanical properties of skeletal muscle
and on pain perception threshold remained to be further
clarified. In future study, in order to integrate current anti-
tumor investigation with biomechanical experiment and
extend its perspective clinical applications, we should take
this limitation into consideration and try to perform in
vivo biomechanical test and pain threshold measurement
in response to SPEF with different frequencies.
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